Shares of EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) traded up 0.8% during mid-day trading on Wednesday . The company traded as high as GBX 25.51 ($0.32) and last traded at GBX 25 ($0.32). Approximately 4,511,308 shares changed hands during mid-day trading, an increase of 1,017% from the average daily volume of 403,962 shares. The stock had previously closed at GBX 24.80 ($0.31).
EKF Diagnostics Stock Up 3.6 %
The business’s fifty day simple moving average is GBX 26.93 and its 200 day simple moving average is GBX 28.17. The stock has a market cap of £117.97 million, a price-to-earnings ratio of 2,600.00 and a beta of 0.57. The company has a current ratio of 4.59, a quick ratio of 1.77 and a debt-to-equity ratio of 1.78.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Featured Articles
- Five stocks we like better than EKF Diagnostics
- Investing In Preferred Stock vs. Common Stock
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- The How and Why of Investing in Gold Stocks
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What is a Stock Market Index and How Do You Use Them?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
